217 related articles for article (PubMed ID: 31007474)
1. Comparative Study between Mesotherapy and Topical 5% Minoxidil by Dermoscopic Evaluation for Androgenic Alopecia in Male: A Randomized Controlled Trial.
Gajjar PC; Mehta HH; Barvaliya M; Sonagra B
Int J Trichology; 2019; 11(2):58-67. PubMed ID: 31007474
[TBL] [Abstract][Full Text] [Related]
2. Comparing the Efficacy of Mesotherapy to Topical Minoxidil in the Treatment of Female Pattern Hair Loss Using Ultrasound Biomicroscopy: A Randomized Controlled Trial.
Hunter N; Sayed K; Hay RA; Allam R; Hussein N
Acta Dermatovenerol Croat; 2019 Mar; 27(1):1-7. PubMed ID: 31032783
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Low-Level Laser Therapy in Androgenetic Alopecia - A Randomized Controlled Trial.
Sondagar DM; Mehta HH; Agharia RS; Jhavar MK
Int J Trichology; 2023; 15(1):25-32. PubMed ID: 37305186
[TBL] [Abstract][Full Text] [Related]
4. A Randomized Controlled, Single-Observer Blinded Study to Determine the Efficacy of Topical Minoxidil plus Microneedling versus Topical Minoxidil Alone in the Treatment of Androgenetic Alopecia.
Kumar MK; Inamadar AC; Palit A
J Cutan Aesthet Surg; 2018; 11(4):211-216. PubMed ID: 30886475
[TBL] [Abstract][Full Text] [Related]
5. Excellent response to mesotherapy as adjunctive treatment in male androgenetic alopecia.
Melo DF; de Mattos Barreto T; Plata GT; Araujo LR; Tortelly VD
J Cosmet Dermatol; 2020 Jan; 19(1):75-77. PubMed ID: 31066492
[TBL] [Abstract][Full Text] [Related]
6. Dermoscopic evaluation of the efficacy of combination of topical spironolactone 5% and minoxidil 5% solutions in the treatment of androgenetic alopecia: A cross sectional-comparative study.
Ammar AM; Elshahid AR; Abdel-Dayem HA; Mohamed AA; Elsaie ML
J Cosmet Dermatol; 2022 Nov; 21(11):5790-5799. PubMed ID: 36039391
[TBL] [Abstract][Full Text] [Related]
7. Original article: Platelet-rich plasma with microneedling in androgenetic alopecia along with dermoscopic pre- and post-treatment evaluation.
Jha AK; Udayan UK; Roy PK; Amar AKJ; Chaudhary RKP
J Cosmet Dermatol; 2018 Jun; 17(3):313-318. PubMed ID: 28771982
[TBL] [Abstract][Full Text] [Related]
8. Intradermal injections with 0.5% minoxidil for the treatment of female androgenetic alopecia: A randomized, placebo-controlled trial.
Uzel BPC; Takano GHS; Chartuni JCN; Cesetti MV; Gavioli CFB; Lemes AM; Costa IMC
Dermatol Ther; 2021 Jan; 34(1):e14622. PubMed ID: 33269529
[TBL] [Abstract][Full Text] [Related]
9. A Comparative Study of Microneedling with Platelet-rich Plasma Plus Topical Minoxidil (5%) and Topical Minoxidil (5%) Alone in Androgenetic Alopecia.
Shah KB; Shah AN; Solanki RB; Raval RC
Int J Trichology; 2017; 9(1):14-18. PubMed ID: 28761259
[TBL] [Abstract][Full Text] [Related]
10. Frontal edema due to mesotherapy for androgenetic alopecia: A case series.
Melo DF; Saceda-Corralo D; Tosti A; Weffort F; Carla Jorge M; de Barros CC; de Melo Carvalho R; Starace M
Dermatol Ther; 2022 Feb; 35(2):e15247. PubMed ID: 34877759
[TBL] [Abstract][Full Text] [Related]
11. Mesotherapy as a Promising Alternative to Minoxidil for Androgenetic Alopecia: A Systematic Review.
Aledani EM; Kaur H; Kasapoglu M; Yadavalli R; Nawaz S; Althwanay A; Nath TS
Cureus; 2024 May; 16(5):e59705. PubMed ID: 38841017
[TBL] [Abstract][Full Text] [Related]
12. Platelet-rich plasma and microneedling improves hair growth in patients ofandrogenetic alopecia when used as an adjuvant to minoxidil.
Jha AK; Vinay K; Zeeshan M; Roy PK; Chaudhary RKP; Priya A
J Cosmet Dermatol; 2019 Oct; 18(5):1330-1335. PubMed ID: 30693667
[TBL] [Abstract][Full Text] [Related]
13. Comparison of 5% minoxidil lotion monotherapy versus its combination with autologous platelet rich plasma in androgenetic alopecia in hundred males.
Ray R; Sharma A
Med J Armed Forces India; 2021 Jul; 77(3):355-362. PubMed ID: 34305291
[TBL] [Abstract][Full Text] [Related]
14. Comparative histological and immunohistochemical study on the effect of platelet rich plasma/minoxidil, alone or in combination, on hair growth in a rat model of androgenic alopecia.
Elsebay SAG; Nada HF; Sultan NSS; El-Waseef DAEA
Tissue Cell; 2022 Apr; 75():101726. PubMed ID: 35030343
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial.
Shin HS; Won CH; Lee SH; Kwon OS; Kim KH; Eun HC
Am J Clin Dermatol; 2007; 8(5):285-90. PubMed ID: 17902730
[TBL] [Abstract][Full Text] [Related]
16. An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia.
Arca E; Açikgöz G; Taştan HB; Köse O; Kurumlu Z
Dermatology; 2004; 209(2):117-25. PubMed ID: 15316165
[TBL] [Abstract][Full Text] [Related]
17. A randomized evaluator blinded study of effect of microneedling in androgenetic alopecia: a pilot study.
Dhurat R; Sukesh M; Avhad G; Dandale A; Pal A; Pund P
Int J Trichology; 2013 Jan; 5(1):6-11. PubMed ID: 23960389
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of QR678 and QR678 Neo
Shome D; Kapoor R; Doshi K; Patel G; Vadera S; Kumar V
J Cosmet Dermatol; 2022 Jan; 21(1):358-367. PubMed ID: 34825770
[TBL] [Abstract][Full Text] [Related]
19. A Randomized, Controlled Pilot Trial Comparing Platelet-Rich Plasma to Topical Minoxidil Foam for Treatment of Androgenic Alopecia in Women.
Bruce AJ; Pincelli TP; Heckman MG; Desmond CM; Arthurs JR; Diehl NN; Douglass EJ; Bruce CJ; Shapiro SA
Dermatol Surg; 2020 Jun; 46(6):826-832. PubMed ID: 31574029
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of 5% Minoxidil Alone, Minoxidil Plus Oral Spironolactone, and Minoxidil Plus Microneedling on Female Pattern Hair Loss: A Prospective, Single-Center, Parallel-Group, Evaluator Blinded, Randomized Trial.
Liang X; Chang Y; Wu H; Liu Y; Zhao J; Wang L; Zhuo F
Front Med (Lausanne); 2022; 9():905140. PubMed ID: 35899211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
